News
Several of America's tech giants posted better-than-expected earnings this week, even as worries about the economy in the ...
Legend Biotech (LEGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
11h
Zacks Investment Research on MSNWall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a BetLegend Biotech Corporation Sponsored ADR (LEGN) closed the last trading session at $33.96, gaining 3.3% over the past four ...
Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Good day and thank you for standing by. Welcome to the ICON plc Q1 ...
For most of us, taking Alexandria private is a theoretical exercise. Instead, we must be content with purchasing fractions of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results